Tech Company Financing Transactions
Ambit Biosciences Funding Round
Ambit Biosciences closed a $50 million funding round on 11/6/2012. Investors included OrbiMed, Aisling Capital and Forward Ventures.
OrbiMed (Lead Investor) (David Bonita)
Aisling Capital (Steven Elms)
Forward Ventures (Standish Fleming)
Growthworks Capital (Joseph Regan)
San Diego, CA 92121
Browse more venture capital transactions:
Prev: 11/6/2012: Xunlight venture capital transaction
Next: 11/6/2012: OrderGroove venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs